Literature DB >> 7610496

gp120 and neurotoxicity in vivo.

S A Lipton, D E Brenneman, F S Silverstein, E Masliah, L Mucke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7610496     DOI： 10.1016/s0165-6147(00)88998-1

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  9 in total

1.  Growth-associated protein-43 and ephrin B3 induction in the brain of adult SIV-infected rhesus macaques.

Authors:  Susan V Westmoreland; Lakshmanan Annamalai; Margaret R Lentz; Eva-Marie Ratai; Basel Assaf; Karen Boisvert; Thanhthao Huynh; Eric J Vallender; Gregory M Miller; Bertha K Madras; R Gilberto Gonzalez
Journal:  J Neurovirol       Date:  2011-07-26       Impact factor: 2.643

2.  Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures.

Authors:  Sylvia Fitting; Rosemarie M Booze; Charles F Mactutus
Journal:  Brain Res       Date:  2008-07-17       Impact factor: 3.252

3.  Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.

Authors:  Sylvia Fitting; Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2017-10-27       Impact factor: 2.457

Review 4.  Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS.

Authors:  Leslie Crews; Margaret R Lentz; R Gilberto Gonzalez; Howard S Fox; Eliezer Masliah
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

5.  Differential long-term neurotoxicity of HIV-1 proteins in the rat hippocampal formation: a design-based stereological study.

Authors:  Sylvia Fitting; Rosemarie M Booze; Ulla Hasselrot; Charles F Mactutus
Journal:  Hippocampus       Date:  2008       Impact factor: 3.899

Review 6.  Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders.

Authors:  Jerel Fields; Wilmar Dumaop; T D Langford; Edward Rockenstein; E Masliah
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-08       Impact factor: 4.147

7.  Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation.

Authors:  Landhing M Moran; Sylvia Fitting; Rosemarie M Booze; Katy M Webb; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2014-10-05       Impact factor: 2.457

8.  GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration.

Authors:  Pedro Miguel Salcedo Gómez; Masayuki Amano; Sofiya Yashchuk; Akira Mizuno; Debananda Das; Arun K Ghosh; Hiroaki Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  2013-09-30       Impact factor: 5.191

Review 9.  HIV-1 associated dementia: symptoms and causes.

Authors:  Mohammad Ghafouri; Shohreh Amini; Kamel Khalili; Bassel E Sawaya
Journal:  Retrovirology       Date:  2006-05-19       Impact factor: 4.602
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.